People · Operator
Named in public records as an officer, director or promoter · active 2018–2018 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ideaya Biosciences, Inc. | — | Biotechnology | Series C | $111.4M | $3.9B | 2018 |
Jeffrey P. Hager at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeffrey P. Hager on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Timothy Shannon | 1 | 9 |
| Brian Daniels | 1 | 5 |
| Paul Stone | 1 | 5 |
| Jeffrey Stein | 1 | 4 |
| Terry Rosen | 1 | 4 |
| John D. Diekman | 1 | 4 |
| John Diekman | 1 | 3 |
| Yujiro Hata | 1 | 3 |
| Thilo P. Schroeder | 1 | 2 |
| Paul A. Stone | 1 | 1 |
| Yujiro S. Hata | 1 | 1 |
| Edward P. Hu | 1 | 1 |
| Jeffrey S. Stein | 1 | 1 |
| Terry S. Rosen | 1 | 1 |
| Timothy S. Shannon | 1 | 1 |
| Tim P. Smith | 1 | 1 |
| Michael P. Dillon | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.